Charles Schwab Investment Management Inc Vera Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 430,665 shares of VERA stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
430,665
Previous 361,805
19.03%
Holding current value
$11.7 Million
Previous $16 Million
13.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$152 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$119 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$90.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$80.2 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$79.9 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $732M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...